-
AmerisourceBergen Primed For A Bounce
Post on 1/6/21
-
Aro Biotherapeutics Closes $88 Million Series A
Post on 1/5/21
-
Quest Diagnostics: A COVID-19 Beneficiary
Post on 1/5/21
-
ADMA Biologics: A Perfect Storm
Post on 1/5/21
-
Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%
Post on 1/5/21
-
Flowonix Medical and SWK Holdings Closes $33M Financing
Post on 1/4/21
-
Dun & Bradstreet - Increasingly Appealing
Post on 1/4/21
-
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
Post on 1/4/21
-
Pfizer's Next Multibillion-Dollar COVID Vaccine Move
Post on 1/4/21
-
Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial?
Post on 1/4/21
-
Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?
Post on 1/4/21
-
Is Johnson & Johnson Stock a Buy?
Post on 12/24/20
-
Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine
Post on 12/24/20
-
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
Post on 12/23/20
-
Is Pfizer's COVID Vaccine Growth Story Already Over?
Post on 12/23/20
-
What Pfizer Wants You to Know About Its COVID Vaccine
Post on 12/23/20
-
Acorn Bioventures Invests in Cyclacel Pharmaceuticals
Post on 12/22/20
-
SCYNEXIS Closes of $85 Million Public Offering of Common Stock
Post on 12/22/20
-
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology
Post on 12/22/20
-
Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe
Post on 12/22/20
-
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Post on 12/21/20
-
CapStone Holdings Invests $25 Million in Ilera Healthcare
Post on 12/21/20
-
CapStone Holdings Invests $25 Million in Ilera Healthcare
Post on 12/21/20
-
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Post on 12/21/20
-
Did U.K. and Canadian Authorizations of Pfizer's COVID Vaccine Pressure the U.S.?
Post on 12/21/20
Philadelphia
